The Future for Effective Healthcare Supply Change Is Balancing Cost, Quality, and Outcomes

By Michael Louviere

Supply chain must play an integral role in the care delivery process through cross-departmental partnerships that support evidence-based value analysis. Michael Louviere, System VP of Supply Chain at OHS shares his insights on what he calls a 'new adventureattempting to support best practices by collecting clinical evidence and synthesizing it to ensure that clinical practice is based on integrating individual clinical expertise with the best available relevant external clinical evidence from systematic research.

Related Resources

Advisory
CMS Releases Proposed Rule for Hospital Value-Based Purchasing Program
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program t
Letter/Comment
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Advisory
Final Regulations on Taxable Medical Devices
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ
Toolkits/Methodology
Guidance for Writing Comments
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…
Advisory
UDI and Adverse Event Reporting Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.
Letter/Comment
IRS Issues Final Rule Implementing Medical Device Excise Tax
An announcement of the Final Rule issued by the IRS.